The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.00
Bid: 18.00
Ask: 20.00
Change: -0.20 (-1.04%)
Spread: 2.00 (11.111%)
Open: 19.00
High: 20.40
Low: 19.00
Prev. Close: 19.20
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directa Plus receives two new Italian patents

29 Jun 2023 07:00

RNS Number : 3038E
Directa Plus PLC
29 June 2023
 

RNS Reach

29 June 2023

 

Directa Plus plc

("Directa Plus", the "Group" or the "Company")

 

Directa Plus receives two new Italian patents

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, has been granted two new Italian patents, the EP patent, which relates to the 'apparatus for treating materials with plasma', and the ET patent, which relates to the 'composition comprising graphene for the treatment of textile articles'.

 

These new grants represent a step forward in Directa Plus' intellectual property strategy and protects the Company's unique production process and the evolution of its graphene technology. Following the grant of the two patents, Directa Plus' IP portfolio now comprises of 22 patent families, with 84 patents granted and 38 patents pending.

 

EP patent

Covers the apparatus for treating materials with plasma, in particular a device comprising a plasma microwave generator, a waveguide, and a microwave system torch, suitable for generating and sustaining atmospheric thermal plasma for treating powder materials. This is key to the Group's IP strategy as plasma technology sits at the core of Directa Plus' unique production process and is what distinguishes the Company from its competitors. Through its plasma technology, Directa Plus generates super-expanded graphite (Grafysorber®) with unique properties and performances in a chemical-free process. The EP patent is the technical evolution of the patent for 'production of nano-structures', and covers all the engineering improvements made to the plasma system to enhance the performance of the technology in terms of yields and the quality of the super expanded graphite obtained. The patent priority date is 19 December 2018.

 

ET Patent

Covers the composition for treating textile articles and is a further evolution of the use of G+ in textiles, expanding the Group's patent coverage in textile applications. It covers a 100% natural and environmentally sustainable printing paste enhanced by graphene's antimicrobial, electrical and thermal conductivity properties. The patent also protects textile articles treated with the composition, including manufactured products for personal health protection. The natural make-up of this composition firmly aligns with Directa Plus' focus on sustainability and environmental protection. The patent priority date is the 4 May 2021.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "Receiving a further two patents has not only strengthened Directa Plus' IP portfolio but demonstrates the ability of our graphene technology to be used across a range of applications and reinforces our position in fast growing markets. As we look to further our competitive advantage, we will continue to aggressively expand our portfolio, covering both technology and applications."

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

Giorgio Bonfanti, CFO

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald

Adam Rae

Singer Capital Markets Securities Limited (Joint Broker)

+44 20 7496 3069

Rick Thompson

Phil Davies

Alma PR (Financial PR Adviser)

+44 20 3405 0205

Justine James

directaplus@almapr.co.uk

Hannah Campbell

Kinvara Verdon

 

 

Notes to Editors

 

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products.

 

Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+(R)) have multiple applications due to its properties. These G+(R) products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. Directa Plus holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUWORRORUNUUR
Date   Source Headline
31st Jul 20187:00 amRNSAppointment of N+1 Singer as Joint Broker
9th Jul 201810:00 amRNSOakley and Bioracer launch Graphene Plus jersey
4th Jul 20187:00 amRNSSecond significant order from Alfredo Grassi
18th Jun 20184:28 pmRNSResult of AGM
18th Jun 20187:00 amRNSAGM Statement
1st Jun 20187:00 amRNSTransfer in Significant Shareholding
25th May 20187:00 amRNSNotice of AGM
14th May 20187:00 amRNSExclusive Collaboration Agreement with Arvind
2nd May 20181:06 pmRNSDirector Share Purchase
1st May 201810:56 amRNSDirector Share Purchase
30th Apr 20187:00 amRNSAgreement with Global Leader in Luxury Accessories
26th Apr 20187:00 amRNSDirectorate Change
26th Apr 20187:00 amRNSFinal Results
23rd Apr 20187:00 amRNSStrategic Collaboration with Marangoni Group
9th Apr 20188:25 amRNSSuccessful Grafysorber® field test with OMV Petrom
21st Mar 20187:00 amRNSSartec agreement to commercialise Grafysorber®
19th Feb 20187:00 amRNSPatent for G+ elastomeric composition for tyres
6th Feb 20187:07 amRNSColmar and Eurojersey launch new G+ collections
24th Jan 20187:00 amRNSUS patent for graphene flame-retardant composition
15th Jan 20187:00 amRNSPre-Close Trading Update
21st Dec 20177:00 amRNSOrder from Vittoria
14th Dec 20177:00 amRNSCollaboration with GSP SA on Grafysorber®
23rd Nov 20177:00 amRNSDirecta Plus and Iterchimica develop Eco Pave
14th Nov 20177:00 amRNSG+ textiles certified as 'non-irritating'
11th Oct 201712:27 pmRNSDirector/PDMR Shareholding
10th Oct 20171:13 pmRNSPDMR Shareholding
28th Sep 20177:01 amRNSContract with Alfredo Grassi to supply G+ graphene
28th Sep 20177:00 amRNSInterim Results
21st Aug 20177:00 amRNSAppointment of Luca Provolo as Head of Sales
3rd Aug 20174:35 pmRNSPrice Monitoring Extension
22nd Jun 20177:00 amRNSDirecta Plus collaboration with Alfredo Grassi
7th Jun 20173:54 pmRNSResult of AGM
7th Jun 20172:22 pmRNSAGM Statement
25th May 201710:46 amRNSDirector Dealing
12th May 20177:00 amRNSAnnual Report Posting, AGM Notice & Options Grant
9th May 201711:05 amRNSDirector/PDMR Shareholding
5th May 20177:00 amRNSDirector Dealing
4th May 201710:47 amRNSDealing by Proposed Director
4th May 20177:00 amRNSDirector/PDMR Shareholding
28th Apr 201711:00 amRNSPrice Monitoring Extension
28th Apr 20179:50 amRNSDirectorate Changes
28th Apr 20177:00 amRNSFinal Results
20th Feb 20177:00 amRNSGrant Award for Textiles Project
2nd Dec 20167:00 amRNSCustomer Announcement
22nd Nov 20167:00 amRNSDirecta Plus Achieves ISO 14001:2015 Certification
14th Nov 20167:00 amRNSAcquisition and Directa Textile Solutions launch
18th Oct 20167:01 amRNSFurther two patents granted
18th Oct 20167:00 amRNSCustomer announcement
21st Sep 20167:00 amRNSInterim Results
15th Sep 201610:30 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.